Literature DB >> 22641094

A hedgehog survival pathway in 'undead' lipotoxic hepatocytes.

Keisuke Kakisaka1, Sophie C Cazanave, Nathan W Werneburg, Nataliya Razumilava, Joachim C Mertens, Steve F Bronk, Gregory J Gores.   

Abstract

BACKGROUND & AIMS: Ballooned hepatocytes in non-alcoholic steatohepatitis (NASH) generate sonic hedgehog (SHH). This observation is consistent with a cellular phenotype in which the cell death program has been initiated but cannot be executed. Our aim was to determine whether ballooned hepatocytes have potentially disabled the cell death execution machinery, and if so, can their functional biology be modeled in vitro.
METHODS: Immunohistochemistry was performed on human NASH specimens. In vitro studies were performed using HuH-7 cells with shRNA targeted knockdown of caspase 9 (shC9 cells) or primary hepatocytes from caspase 3(-/-) mice.
RESULTS: Ballooned hepatocytes in NASH display diminished expression of caspase 9. This phenotype was modeled using shC9 cells; these cells were resistant to lipoapoptosis by palmitate (PA) or lysophosphatidylcholine (LPC) despite lipid droplet formation. During lipid loading by either PA or LPC, shC9 cells activate JNK which induces SHH expression via AP-1. An autocrine hedgehog survival signaling pathway was further delineated in both shC9 and caspase 3(-/-) cells during lipotoxic stress.
CONCLUSIONS: Ballooned hepatocytes in NASH downregulate caspase 9, a pivotal caspase executing the mitochondrial pathway of apoptosis. Hepatocytes engineered to reduce caspase 9 expression are resistant to lipoapoptosis, in part, due to a hedgehog autocrine survival signaling pathway.
Copyright © 2012 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22641094      PMCID: PMC3467008          DOI: 10.1016/j.jhep.2012.05.011

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  39 in total

Review 1.  Caspase-independent cell death.

Authors:  Guido Kroemer; Seamus J Martin
Journal:  Nat Med       Date:  2005-07       Impact factor: 53.440

2.  Distinct mechanisms of apoptosis-induced compensatory proliferation in proliferating and differentiating tissues in the Drosophila eye.

Authors:  Yun Fan; Andreas Bergmann
Journal:  Dev Cell       Date:  2008-03       Impact factor: 12.270

3.  Fluorescent detection of lipid droplets and associated proteins.

Authors:  Laura L Listenberger; Deborah A Brown
Journal:  Curr Protoc Cell Biol       Date:  2007-06

4.  DRONC coordinates cell death and compensatory proliferation.

Authors:  Shu Kondo; Nanami Senoo-Matsuda; Yasushi Hiromi; Masayuki Miura
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

5.  Compensatory proliferation in Drosophila imaginal discs requires Dronc-dependent p53 activity.

Authors:  Brent S Wells; Eri Yoshida; Laura A Johnston
Journal:  Curr Biol       Date:  2006-08-22       Impact factor: 10.834

Review 6.  Cellular and molecular mechanisms of liver injury.

Authors:  Harmeet Malhi; Gregory J Gores
Journal:  Gastroenterology       Date:  2008-05       Impact factor: 22.682

7.  Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.

Authors:  Mara Monetti; Malin C Levin; Matthew J Watt; Mini P Sajan; Stephen Marmor; Brian K Hubbard; Robert D Stevens; James R Bain; Christopher B Newgard; Robert V Farese; Andrea L Hevener; Robert V Farese
Journal:  Cell Metab       Date:  2007-07       Impact factor: 27.287

Review 8.  Apoptosis-induced compensatory proliferation. The Cell is dead. Long live the Cell!

Authors:  Yun Fan; Andreas Bergmann
Journal:  Trends Cell Biol       Date:  2008-09-04       Impact factor: 20.808

9.  Ballooned hepatocytes in steatohepatitis: the value of keratin immunohistochemistry for diagnosis.

Authors:  Carolin Lackner; Margit Gogg-Kamerer; Kurt Zatloukal; Conny Stumptner; Elizabeth M Brunt; Helmut Denk
Journal:  J Hepatol       Date:  2008-02-22       Impact factor: 25.083

10.  Activation of the BCL2 promoter in response to Hedgehog/GLI signal transduction is predominantly mediated by GLI2.

Authors:  Gerhard Regl; Maria Kasper; Harald Schnidar; Thomas Eichberger; Graham W Neill; Michael P Philpott; Harald Esterbauer; Cornelia Hauser-Kronberger; Anna-Maria Frischauf; Fritz Aberger
Journal:  Cancer Res       Date:  2004-11-01       Impact factor: 12.701

View more
  30 in total

1.  Reversing Advanced Hepatic Fibrosis in NASH: Clearly Possible, but Widely at Hand?

Authors:  Stephen H Caldwell; Curtis K Argo
Journal:  Dig Dis Sci       Date:  2015-01-25       Impact factor: 3.199

2.  Response to the letter by Sumida et al. regarding our manuscript "Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease".

Authors:  Keisuke Kakisaka; Yuji Suzuki; Yudai Fujiwara; Tamami Abe; Miki Yonezawa; Hidekatsu Kuroda; Kazuyuki Ishida; Tamotsu Sugai; Yasuhiro Takikawa
Journal:  J Gastroenterol       Date:  2019-03-26       Impact factor: 7.527

3.  Treatment response in the PIVENS trial is associated with decreased Hedgehog pathway activity.

Authors:  Cynthia D Guy; Ayako Suzuki; Manal F Abdelmalek; James L Burchette; Anna Mae Diehl
Journal:  Hepatology       Date:  2014-08-25       Impact factor: 17.425

Review 4.  Liver zonation: Novel aspects of its regulation and its impact on homeostasis.

Authors:  Rolf Gebhardt; Madlen Matz-Soja
Journal:  World J Gastroenterol       Date:  2014-07-14       Impact factor: 5.742

5.  Inhibitory effects of Citrus unshiu pericarpium extracts on palmitate-induced lipotoxicity in HepG2 cells.

Authors:  Young Youn; Young-Soo Kim
Journal:  Food Sci Biotechnol       Date:  2016-12-31       Impact factor: 2.391

Review 6.  Non-alcoholic steatohepatitis pathogenesis: sublethal hepatocyte injury as a driver of liver inflammation.

Authors:  Samar H Ibrahim; Petra Hirsova; Gregory J Gores
Journal:  Gut       Date:  2018-01-24       Impact factor: 23.059

7.  Evaluation of ballooned hepatocytes as a risk factor for future progression of fibrosis in patients with non-alcoholic fatty liver disease.

Authors:  Keisuke Kakisaka; Yuji Suzuki; Yudai Fujiwara; Tamami Abe; Miki Yonezawa; Hidekatsu Kuroda; Kazuyuki Ishida; Tamotsu Sugai; Yasuhiro Takikawa
Journal:  J Gastroenterol       Date:  2018-04-21       Impact factor: 7.527

Review 8.  The hedgehog pathway in nonalcoholic fatty liver disease.

Authors:  Mariana Verdelho Machado; Anna Mae Diehl
Journal:  Crit Rev Biochem Mol Biol       Date:  2018-03-20       Impact factor: 8.250

9.  Noninvasive diagnostic criteria for nonalcoholic steatohepatitis based on gene expression levels in peripheral blood mononuclear cells.

Authors:  Akira Kado; Takeya Tsutsumi; Kenichiro Enooku; Hidetaka Fujinaga; Kazuhiko Ikeuchi; Kazuya Okushin; Kyoji Moriya; Hiroshi Yotsuyanagi; Kazuhiko Koike
Journal:  J Gastroenterol       Date:  2019-03-04       Impact factor: 7.527

10.  Reduced lipoapoptosis, hedgehog pathway activation and fibrosis in caspase-2 deficient mice with non-alcoholic steatohepatitis.

Authors:  M V Machado; G A Michelotti; T de Almeida Pereira; J Boursier; L Kruger; M Swiderska-Syn; G Karaca; G Xie; C D Guy; B Bohinc; K R Lindblom; E Johnson; S Kornbluth; A M Diehl
Journal:  Gut       Date:  2014-07-22       Impact factor: 23.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.